Loading...
Pulmonary embolism (PE) represents a broad spectrum of disease. Risk stratification of patients with PE is necessary to help guide management and disposition decisions.
Researchers retrospectively evaluated the performance of four risk stratification tools — the Pulmonary Embolism Severity Index (PESI); the simplified version, sPESI; the Bova score; and the European Society of Cardiology (ESC) risk score — in patients who were referred for evaluation by Pulmonary Embolism Response Teams (PERTs) at 8 centers. Patients were generally referred for guidance regarding clinical care.
Among 416 adult patients, all-cause mortality was 6.0% at 7 days and 12.3% at 30 days. Roughly 55% received an intervention in addition to anticoagulation (e.g., embol…